vs

Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Ribbon Communications Inc. (RBBN). Click either name above to swap in a different company.

COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $162.6M, roughly 1.3× Ribbon Communications Inc.). Ribbon Communications Inc. runs the higher net margin — 54.8% vs 8.3%, a 46.5% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs -10.3%). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs -8.1%).

Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.

Ribbon Communications Inc. is a public company that makes software, IP and optical networking solutions for service providers, enterprises and critical infrastructure sectors. The company was formed in 2017, following the merger of Genband and Sonus Networks and is headquartered in Plano, Texas.

COLL vs RBBN — Head-to-Head

Bigger by revenue
COLL
COLL
1.3× larger
COLL
$205.4M
$162.6M
RBBN
Growing faster (revenue YoY)
COLL
COLL
+23.2% gap
COLL
12.9%
-10.3%
RBBN
Higher net margin
RBBN
RBBN
46.5% more per $
RBBN
54.8%
8.3%
COLL
Faster 2-yr revenue CAGR
COLL
COLL
Annualised
COLL
19.1%
-8.1%
RBBN

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
COLL
COLL
RBBN
RBBN
Revenue
$205.4M
$162.6M
Net Profit
$17.0M
$89.1M
Gross Margin
62.5%
42.9%
Operating Margin
29.6%
37.6%
Net Margin
8.3%
54.8%
Revenue YoY
12.9%
-10.3%
Net Profit YoY
35.3%
EPS (diluted)
$0.48
$0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COLL
COLL
RBBN
RBBN
Q1 26
$162.6M
Q4 25
$205.4M
$227.3M
Q3 25
$209.4M
$215.4M
Q2 25
$188.0M
$220.6M
Q1 25
$177.8M
$181.3M
Q4 24
$181.9M
$251.4M
Q3 24
$159.3M
$210.2M
Q2 24
$145.3M
$192.6M
Net Profit
COLL
COLL
RBBN
RBBN
Q1 26
$89.1M
Q4 25
$17.0M
Q3 25
$31.5M
$-12.1M
Q2 25
$12.0M
$-11.1M
Q1 25
$2.4M
$-26.2M
Q4 24
$12.5M
Q3 24
$9.3M
$-13.4M
Q2 24
$19.6M
$-16.8M
Gross Margin
COLL
COLL
RBBN
RBBN
Q1 26
42.9%
Q4 25
62.5%
53.3%
Q3 25
61.7%
50.1%
Q2 25
57.7%
49.6%
Q1 25
54.8%
45.4%
Q4 24
54.0%
55.7%
Q3 24
60.8%
52.1%
Q2 24
62.5%
50.8%
Operating Margin
COLL
COLL
RBBN
RBBN
Q1 26
37.6%
Q4 25
29.6%
4.1%
Q3 25
29.7%
1.3%
Q2 25
18.7%
1.9%
Q1 25
12.2%
-10.8%
Q4 24
20.9%
13.2%
Q3 24
21.9%
-0.4%
Q2 24
32.7%
-1.0%
Net Margin
COLL
COLL
RBBN
RBBN
Q1 26
54.8%
Q4 25
8.3%
Q3 25
15.0%
-5.6%
Q2 25
6.4%
-5.0%
Q1 25
1.4%
-14.5%
Q4 24
6.9%
Q3 24
5.9%
-6.4%
Q2 24
13.5%
-8.7%
EPS (diluted)
COLL
COLL
RBBN
RBBN
Q1 26
$0.50
Q4 25
$0.48
$0.50
Q3 25
$0.84
$-0.07
Q2 25
$0.34
$-0.06
Q1 25
$0.07
$-0.15
Q4 24
$0.36
$0.05
Q3 24
$0.27
$-0.08
Q2 24
$0.52
$-0.10

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COLL
COLL
RBBN
RBBN
Cash + ST InvestmentsLiquidity on hand
$386.7M
$67.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$301.7M
$419.1M
Total Assets
$1.7B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COLL
COLL
RBBN
RBBN
Q1 26
$67.6M
Q4 25
$386.7M
$96.4M
Q3 25
$285.9M
$74.8M
Q2 25
$222.2M
$60.5M
Q1 25
$197.8M
$71.2M
Q4 24
$162.8M
$87.8M
Q3 24
$120.0M
$37.2M
Q2 24
$271.6M
$64.6M
Total Debt
COLL
COLL
RBBN
RBBN
Q1 26
Q4 25
$342.1M
Q3 25
$344.3M
Q2 25
$346.5M
Q1 25
$347.4M
Q4 24
$348.3M
Q3 24
$349.1M
Q2 24
$350.0M
Stockholders' Equity
COLL
COLL
RBBN
RBBN
Q1 26
$419.1M
Q4 25
$301.7M
$449.0M
Q3 25
$274.8M
$360.1M
Q2 25
$232.2M
$370.4M
Q1 25
$234.4M
$381.8M
Q4 24
$228.8M
$404.6M
Q3 24
$234.3M
$395.5M
Q2 24
$216.6M
$405.0M
Total Assets
COLL
COLL
RBBN
RBBN
Q1 26
Q4 25
$1.7B
$1.2B
Q3 25
$1.6B
$1.1B
Q2 25
$1.6B
$1.1B
Q1 25
$1.6B
$1.1B
Q4 24
$1.7B
$1.2B
Q3 24
$1.6B
$1.1B
Q2 24
$1.1B
$1.1B
Debt / Equity
COLL
COLL
RBBN
RBBN
Q1 26
Q4 25
0.76×
Q3 25
0.96×
Q2 25
0.94×
Q1 25
0.91×
Q4 24
0.86×
Q3 24
0.88×
Q2 24
0.86×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COLL
COLL
RBBN
RBBN
Operating Cash FlowLast quarter
$123.0M
Free Cash FlowOCF − Capex
$122.4M
FCF MarginFCF / Revenue
59.6%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
7.25×
TTM Free Cash FlowTrailing 4 quarters
$327.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COLL
COLL
RBBN
RBBN
Q1 26
Q4 25
$123.0M
$29.2M
Q3 25
$78.4M
$26.5M
Q2 25
$72.4M
$-795.0K
Q1 25
$55.4M
$-3.5M
Q4 24
$84.6M
$61.8M
Q3 24
$-9.0M
$-14.8M
Q2 24
$67.4M
$-9.8M
Free Cash Flow
COLL
COLL
RBBN
RBBN
Q1 26
Q4 25
$122.4M
$27.3M
Q3 25
$78.3M
$21.0M
Q2 25
$72.4M
$-6.5M
Q1 25
$54.6M
$-15.7M
Q4 24
$84.1M
$53.8M
Q3 24
$-9.2M
$-23.7M
Q2 24
$67.1M
$-12.9M
FCF Margin
COLL
COLL
RBBN
RBBN
Q1 26
Q4 25
59.6%
12.0%
Q3 25
37.4%
9.7%
Q2 25
38.5%
-2.9%
Q1 25
30.7%
-8.7%
Q4 24
46.2%
21.4%
Q3 24
-5.8%
-11.3%
Q2 24
46.2%
-6.7%
Capex Intensity
COLL
COLL
RBBN
RBBN
Q1 26
Q4 25
0.3%
0.9%
Q3 25
0.1%
2.6%
Q2 25
0.0%
2.6%
Q1 25
0.4%
6.7%
Q4 24
0.3%
3.2%
Q3 24
0.2%
4.2%
Q2 24
0.2%
1.6%
Cash Conversion
COLL
COLL
RBBN
RBBN
Q1 26
Q4 25
7.25×
Q3 25
2.49×
Q2 25
6.05×
Q1 25
22.92×
Q4 24
6.75×
Q3 24
-0.96×
Q2 24
3.44×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COLL
COLL

Segment breakdown not available.

RBBN
RBBN

Service$94.5M58%
Product$68.1M42%

Related Comparisons